X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/pharnext-blames-unexpected-placebo-results-lead-neurological-drugs-phase-3-failure
https://www.fiercebiotech.com/biotech/pharnext-ditches-alzheimers-plans-saying-more-development-would-be-too-costly
https://www.accesswire.com/733937/Pharnext-Strengthens-its-Senior-Leadership-Team-with-the-Appointment-of-Scott-Johnson-as-VP-Head-of-Quality
https://www.biospace.com/article/releases/pharnext-strengthens-its-ties-with-neovacs-to-secure-the-next-steps-in-its-development/
https://www.accesswire.com/728953/The-Board-of-Directors-of-Pharnext-Acknowledges-the-Resignation-of-Dr-David-Horn-SOLOMON-from-his-Duties-as-Chief-Executive-Officer-and-Director-of-the-Company
https://www.accesswire.com/728953/The-Board-of-Directors-of-Pharnext-Acknowledges-the-Resignation-of-Dr-David-Horn-SOLOMON-from-his-Duties-as-Chief-Executive-Officer-and-Director-of-the-Company
https://www.accesswire.com/724513/Hugo-Brugire-Joins-Pharnext-Board-of-Directors
https://www.accesswire.com/723118/Pharnext-Announces-that-Neovacs-Has-Set-Up-a-Management-Trust-to-Manage-the-Pharnext-Securities-Issued-and-the-Rights-and-Obligations-of-Neovacs-under-the-Financing-Agreement-Signed-on-September-30th
https://www.accesswire.com/720603/Pharnext-Reports-First-Half-2022-Financial-Results
https://www.accesswire.com/718531/Pharnext-Executes-a-Financing-Agreement-with-Novacs-for-EUR-207-million-Net-to-Further-Develop-PXT3003-for-Charcot-Marie-Tooth-Disease-Type-1A
Market Place
Share 
